AstraZeneca(AZN)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£39,091m

Change Today

Price Up4.00p

Share Price

2,693.00p

Latest ShareCast News

Sector movers: Southern Cross lifts healthcare

Date: Monday 11 Aug 2008

The health care sector is going well after Southern Cross Healthcare reported an 8% rise in underlying earnings.

AstraZeneca Regulatory News

Total Voting Rights 29-Aug-2008 16:00 RNS
Transaction in Own Shares 29-Aug-2008 07:00 RNS
Transaction in Own Shares 28-Aug-2008 07:00 RNS
Transaction in Own Shares 27-Aug-2008 07:00 RNS
Transaction in Own Shares 26-Aug-2008 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 2,693.00p Price Up
Change Today +4.00p
52 Week High 2,740.00p
52 Week Low 1,748.00p
Volume 3,751,360
Shares Issued 1,451.59m
Market Cap £39,091m
Beta 0.69
RiskGrade 137

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.55% below the market average67.55% below the market average67.55% below the market average67.55% below the market average67.55% below the market average
15.66% below the sector average15.66% below the sector average15.66% below the sector average15.66% below the sector average15.66% below the sector average
Price Trend
69.86% above the market average69.86% above the market average69.86% above the market average69.86% above the market average69.86% above the market average
75.56% above the sector average75.56% above the sector average75.56% above the sector average75.56% above the sector average75.56% above the sector average
Income
5.40% above the market average5.40% above the market average5.40% above the market average5.40% above the market average5.40% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Growth
47.4% below the market average47.4% below the market average47.4% below the market average47.4% below the market average47.4% below the market average
31.51% below the sector average31.51% below the sector average31.51% below the sector average31.51% below the sector average31.51% below the sector average

What The Brokers Say

Strong Buy 15
Buy 3
Neutral 16
Sell 6
Strong Sell 3
Total 43
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Aug-08 06-Feb-08
Paid 15-Sep-08 17-Mar-08
Amount 55.00¢ 135.00¢

Trades for 29-Aug-2008

Time Volume / Share Price
16:36 2,293 @ 2,690.10p
16:36 6,244 @ 2,690.56p
16:39 2,957 @ 2,691.65p
16:52 2,957 @ 2,691.65p
16:36 8,900 @ 2,693.72p

AstraZeneca Key Personnel

CEO David R Brennan
CFO Simon Lowth

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).